Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs.
Colan
Steven D
SD
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D006801:Humans; D020388:Muscular Dystrophy, Duchenne / Q000150:complications* / Q000175:diagnosis* / Q000235:genetics; D012449:Safety
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors